- Home
- GMM vs NOTV Comparison
GMM vs NOTV Comparison
Compare GMM & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- NOTV
- Stock Information
- Founded
- GMM 2017
- NOTV 1974
- Country
- GMM China
- NOTV United States
- Employees
- GMM N/A
- NOTV N/A
- Industry
- GMM
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- GMM
- NOTV Health Care
- Exchange
- GMM Nasdaq
- NOTV Nasdaq
- Market Cap
- GMM 61.9M
- NOTV 72.1M
- IPO Year
- GMM 2023
- NOTV 1997
- Fundamental
- Price
- GMM $2.69
- NOTV $1.96
- Analyst Decision
- GMM
- NOTV Strong Buy
- Analyst Count
- GMM 0
- NOTV 1
- Target Price
- GMM N/A
- NOTV $5.00
- AVG Volume (30 Days)
- GMM 22.6K
- NOTV 438.8K
- Earning Date
- GMM 08-15-2025
- NOTV 08-06-2025
- Dividend Yield
- GMM N/A
- NOTV N/A
- EPS Growth
- GMM 62.17
- NOTV N/A
- EPS
- GMM 6.37
- NOTV N/A
- Revenue
- GMM $41,360,953.00
- NOTV $505,299,000.00
- Revenue This Year
- GMM N/A
- NOTV $4.99
- Revenue Next Year
- GMM N/A
- NOTV $5.39
- P/E Ratio
- GMM $0.41
- NOTV N/A
- Revenue Growth
- GMM 53.82
- NOTV 0.85
- 52 Week Low
- GMM $1.69
- NOTV $1.15
- 52 Week High
- GMM $15.60
- NOTV $6.48
- Technical
- Relative Strength Index (RSI)
- GMM 49.83
- NOTV 46.36
- Support Level
- GMM $2.52
- NOTV $1.86
- Resistance Level
- GMM $2.80
- NOTV $2.33
- Average True Range (ATR)
- GMM 0.23
- NOTV 0.23
- MACD
- GMM -0.01
- NOTV 0.01
- Stochastic Oscillator
- GMM 36.51
- NOTV 33.33
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.